Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate 58118-1189
Product NDC
58118-1189- Manufacturer
- Clinical Solutions Wholesale, Llc
- Dosage Form
- Tablet
- Route
- Sublingual
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- June 27, 2014
- Listing Expires
- December 31, 2027
- Application
- ANDA203326
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine Hydrochloride | 8 mg/1 |
| Naloxone Hydrochloride Dihydrate | 2 mg/1 |
Drug Class
Opioid Antagonist [EPC]Opioid Antagonists [MoA]Partial Opioid Agonist [EPC]
Packaging Options(1)
30 TABLET in 1 BLISTER PACK (58118-1189-8)
External Resources